Thursday, August 30, 2007

The Brave New Real World: A Changing Paradigm for Documenting Product Value and Safety Postapproval

Date: 8/29/2007
Length: 00:15:30
Size: 6.96MB
Thought Leader: Jeff Trotter, Senior VP, Lifecycle Sciences Group, Icon Clinical Research

Jeff Trotter speaks about the need for real-world value and safety in postmarketing research, the current landscape, designing new studies, and how the industry can leverage opportunities in the postapproval environment.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

No comments: